| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NHINational Health Investors, Inc. | 3.83B | 80.43 | 25.70 | 4.8% | 41.42% | 9.83% | 5.32% | 0.83 |
| DHCDiversified Healthcare Trust | 1.33B | 5.50 | -3.55 | 6.04% | -22.9% | -20.85% | 8.43% | 1.49 |
| AHRAmerican Healthcare REIT, Inc. | 8.94B | 47.98 | -165.45 | 11.38% | 1.24% | 1% | 0.94% | 0.81 |
| NHPBPNational Healthcare Properties, Inc. | 18.48 | 2.27% | -22.97% | -12.27% | 1.67 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Revenue | 374.91M | 381.61M | 329.36M | 335.85M | 345.93M | 353.79M |
| Revenue Growth % | - | 0.02% | -0.14% | 0.02% | 0.03% | 0.02% |
| Property Operating Expenses | 234.19M | 243.55M | 205.81M | 213.44M | 217.79M | 221.15M |
| Net Operating Income (NOI) | - | - | - | - | - | - |
| NOI Margin % | - | - | - | - | - | - |
| Operating Expenses | 172.52M | 157.94M | 160.98M | 153.94M | 132.87M | 256.19M |
| G&A Expenses | 20.53M | 21.57M | 16.83M | 17.29M | 18.93M | 22.74M |
| EBITDA | 49.24M | 61.1M | 42.29M | 49.9M | 77.25M | -39.47M |
| EBITDA Margin % | - | - | - | - | - | - |
| Depreciation & Amortization | 81.03M | 80.97M | 79.73M | 81.44M | 81.98M | 84.07M |
| D&A / Revenue % | - | - | - | - | - | - |
| Operating Income | -31.79M | -19.87M | -37.44M | -31.54M | -4.74M | -123.54M |
| Operating Margin % | - | - | - | - | - | - |
| Interest Expense | 56.06M | 51.52M | 47.9M | 51.74M | 66.08M | 69.45M |
| Interest Coverage | -0.57x | -0.39x | -0.78x | -0.61x | -0.07x | -1.78x |
| Non-Operating Income | 61K | 58K | -98K | -3.86M | 1.26M | -2.99M |
| Pretax Income | -87.91M | -71.45M | -85.24M | -79.42M | -72.08M | -190M |
| Pretax Margin % | - | - | - | - | - | - |
| Income Tax | 399K | 4.06M | 203K | 201K | 303K | 262K |
| Effective Tax Rate % | - | - | - | - | - | - |
| Net Income | -87.91M | -75.81M | -85.18M | -79.49M | -72.3M | -189.7M |
| Net Margin % | - | - | - | - | - | - |
| Net Income Growth % | - | 0.14% | -0.12% | 0.07% | 0.09% | -1.62% |
| Funds From Operations (FFO) | - | - | - | - | - | - |
| FFO Margin % | - | - | - | - | - | - |
| FFO Growth % | - | 1.75% | -2.06% | 1.36% | 3.96% | -11.91% |
| FFO per Share | - | - | - | - | - | - |
| FFO Payout Ratio % | - | - | - | - | - | - |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Growth % | - | - | - | - | - | - |
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Assets | 2.33B | 2.29B | 2.21B | 2.18B | 2.15B | 1.95B |
| Asset Growth % | - | -0.02% | -0.03% | -0.02% | -0.02% | -0.09% |
| Real Estate & Other Assets | 1.84B | 1.88B | 1.81B | 1.78B | 1.73B | 1.56B |
| PP&E (Net) | 14.35M | 13.91M | 7.91M | 7.81M | 7.71M | 7.48M |
| Investment Securities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 203.62M | 113.76M | 109.24M | 101.81M | 117.64M | 96.94M |
| Cash & Equivalents | 95.69M | 72.36M | 59.74M | 53.65M | 46.41M | 21.65M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 47.04M | -16.85M | -6.92M | -11.67M | 44.91M | 52.44M |
| Intangible Assets | 21.18M | 23.32M | 23.86M | 25.28M | 26.32M | 22.84M |
| Total Liabilities | 1.22B | 1.33B | 1.17B | 1.18B | 1.24B | 1.26B |
| Total Debt | 1.14B | 1.23B | 1.09B | 1.12B | 1.18B | 1.15B |
| Net Debt | 1.05B | 1.15B | 1.03B | 1.06B | 1.13B | 1.13B |
| Long-Term Debt | 528.28M | 542.7M | 584.24M | 578.7M | 809M | 779.16M |
| Short-Term Borrowings | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Capital Lease Obligations | 9.13M | 9.15M | 8.13M | 8.09M | 8.04M | 8.11M |
| Total Current Liabilities | 663.78M | 724.48M | 556.78M | 584.97M | 419.38M | 462.5M |
| Accounts Payable | 43.09M | 42.27M | 42.71M | 45.25M | 48.36M | 89.58M |
| Deferred Revenue | 8.52M | 6.91M | 8.62M | 5.92M | 6.5M | 7.22M |
| Other Liabilities | 8.84M | 42.28M | 24.85M | 9.41M | 8.16M | 6.13M |
| Total Equity | 1.11B | 961.37M | 1.04B | 999.19M | 900.58M | 690.13M |
| Equity Growth % | - | -0.13% | 0.08% | -0.04% | -0.1% | -0.23% |
| Shareholders Equity | 1.1B | 956.99M | 1.03B | 992.64M | 894.15M | 684.56M |
| Minority Interest | 5.41M | 4.39M | 6.7M | 6.55M | 6.43M | 5.57M |
| Common Stock | 923K | 938K | 993K | 1.05M | 1.11M | 1.13M |
| Additional Paid-in Capital | 2.08B | 2.1B | 2.33B | 2.42B | 2.51B | 2.53B |
| Retained Earnings | -971.19M | -1.11B | -1.28B | -1.46B | -1.64B | -1.87B |
| Preferred Stock | 16K | 16K | 76K | 76K | 76K | 76K |
| Return on Assets (ROA) | -0.04% | -0.03% | -0.04% | -0.04% | -0.03% | -0.09% |
| Return on Equity (ROE) | -0.08% | -0.07% | -0.09% | -0.08% | -0.08% | -0.24% |
| Debt / Assets | 0.49% | 0.54% | 0.49% | 0.51% | 0.55% | 0.59% |
| Debt / Equity | 1.03x | 1.28x | 1.05x | 1.12x | 1.31x | 1.67x |
| Net Debt / EBITDA | 21.26x | 18.89x | 24.46x | 21.31x | 14.65x | - |
| Book Value per Share | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 47.4M | 41.81M | 38.88M | 28.3M | 21.62M | -79.85M |
| Operating CF Growth % | - | -0.12% | -0.07% | -0.27% | -0.24% | -4.69% |
| Operating CF / Revenue % | - | - | - | - | - | - |
| Net Income | -88.31M | -75.51M | -85.44M | -79.62M | -72.38M | -190.26M |
| Depreciation & Amortization | 81.03M | 80.97M | 79.73M | 81.44M | 81.98M | 82.64M |
| Stock-Based Compensation | 1.32M | 1.34M | 1.33M | 1.19M | 919K | 613K |
| Other Non-Cash Items | 62.72M | 38.99M | 43.69M | 32.72M | 16.4M | 24.21M |
| Working Capital Changes | -9.36M | -8.63M | 57K | -10.18M | -6.46M | 558K |
| Cash from Investing | -46.25M | -82.49M | -47.92M | -41.78M | -62.82M | 63.97M |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | -9.96M | -1.71M |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -29.53M | -60.6M | -28.85M | -13.79M | -30.46M | 87.59M |
| Cash from Financing | 19.09M | 19.43M | 4.08M | 4.64M | 55.97M | -1.35M |
| Dividends Paid | -51.43M | -33.75M | -5.14M | -13.8M | -13.8M | -13.8M |
| Common Dividends | -51.43M | -31.35M | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K |
| Share Repurchases | -21.11M | -11.55M | 0 | -42K | 0 | 0 |
| Other Financing | -22.02M | -3.12M | -1.62M | -1.86M | -8.65M | -184K |
| Net Change in Cash | 20.24M | -21.25M | -4.96M | -8.84M | 14.78M | -17.22M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 91.36M | 111.6M | 90.35M | 85.38M | 76.54M | 91.32M |
| Cash at End | 111.6M | 90.35M | 85.38M | 76.54M | 91.32M | 74.09M |
| Free Cash Flow | 30.68M | 19.91M | 19.81M | 302K | -773K | -101.75M |
| FCF Growth % | - | -0.35% | -0.01% | -0.98% | -3.56% | -130.64% |
| FCF / Revenue % | - | - | - | - | - | - |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| FFO Payout Ratio | -746.83% | 607.64% | 0% | 706.55% | 142.49% | 0% |
| NOI Margin | 37.54% | 36.18% | 37.51% | 36.45% | 37.04% | 37.49% |
| Net Debt / EBITDA | 21.26x | 18.89x | 24.46x | 21.31x | 14.65x | - |
| Debt / Assets | 49.14% | 53.63% | 49.42% | 51.23% | 54.92% | 59.07% |
| Interest Coverage | -0.57x | -0.39x | -0.78x | -0.61x | -0.07x | -1.78x |
| Revenue Growth | - | 1.79% | -13.69% | 1.97% | 3% | 2.27% |
National Healthcare Properties, Inc. (NHPBP) reported $348.5M in revenue for fiscal year 2024. This represents a 7% decrease from $374.9M in 2019.
National Healthcare Properties, Inc. (NHPBP) grew revenue by 2.3% over the past year. Growth has been modest.
National Healthcare Properties, Inc. (NHPBP) reported a net loss of $80.1M for fiscal year 2024.
National Healthcare Properties, Inc. (NHPBP) has a return on equity (ROE) of -23.9%. Negative ROE indicates the company is unprofitable.
National Healthcare Properties, Inc. (NHPBP) generated Funds From Operations (FFO) of $5.9M in the trailing twelve months. FFO is the primary profitability metric for REITs.